BITTER
Although The Sequence tries its best to sell with flashes of light and projections galore, it ultimately falls prey to its own inability to communicate.
Ariana Mufson – Curtain Up
SWEET
Could the search for the human genomic makeup make for riveting theatre? You bet it can.
Robert Machray – Blog Critics
BITTER
Paul Mullin’s “The Sequence,” currently at The Theatre @ Boston Court, chronicles the race between two scientists to map the human genome. Drawn from real-world events, this flashy and ambitious new play spotlights an important scientific breakthrough but comes up more than a few chromosomes short of a coherent drama.
David Ng – Los Angeles Times
SWEET
Mullin’s often outlandish explanations of the subject make for fascinating rapid-fire entertainment that moves from childlike storytelling to music hall and beyond.
Tom Provenzano – Los Angeles Weekly
SWEET
Stylishly and imaginatively realized by director John Langs and potently delivered by three fine actors, the story is part allegory, part real-life journalism.
Dany Margolies – Backstage
LEMONMETER UPDATE:
Whereas Rotten Tomatoes has an extremely large pool to pull from to create their critics favorability percentage, LA Theatre productions’ pool is much smaller. Therefore, in the desire to be fairly balanced, Bitter Lemons is lowering their “Sweet” cut off line to 60%.
Sweet!
